Metabolic activation of 3-methylcholanthrene and its metabolites to products mutagenic to bacterial and mammalian cells. 1978

A W Wood, and R L Chang, and W Levin, and P E Thomas, and D Ryan, and T A Stoming, and D R Thakker, and D M Jerina, and A H Conney

UI MeSH Term Description Entries
D008297 Male Males
D008748 Methylcholanthrene A carcinogen that is often used in experimental cancer studies. 20-Methylcholanthrene,3-Methylcholanthrene,20 Methylcholanthrene,3 Methylcholanthrene
D008862 Microsomes, Liver Closed vesicles of fragmented endoplasmic reticulum created when liver cells or tissue are disrupted by homogenization. They may be smooth or rough. Liver Microsomes,Liver Microsome,Microsome, Liver
D009153 Mutagens Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes. Clastogen,Clastogens,Genotoxin,Genotoxins,Mutagen
D010105 Oxygenases Oxidases that specifically introduce DIOXYGEN-derived oxygen atoms into a variety of organic molecules. Oxygenase
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003577 Cytochrome P-450 Enzyme System A superfamily of hundreds of closely related HEMEPROTEINS found throughout the phylogenetic spectrum, from animals, plants, fungi, to bacteria. They include numerous complex monooxygenases (MIXED FUNCTION OXYGENASES). In animals, these P-450 enzymes serve two major functions: (1) biosynthesis of steroids, fatty acids, and bile acids; (2) metabolism of endogenous and a wide variety of exogenous substrates, such as toxins and drugs (BIOTRANSFORMATION). They are classified, according to their sequence similarities rather than functions, into CYP gene families (>40% homology) and subfamilies (>59% homology). For example, enzymes from the CYP1, CYP2, and CYP3 gene families are responsible for most drug metabolism. Cytochrome P-450,Cytochrome P-450 Enzyme,Cytochrome P-450-Dependent Monooxygenase,P-450 Enzyme,P450 Enzyme,CYP450 Family,CYP450 Superfamily,Cytochrome P-450 Enzymes,Cytochrome P-450 Families,Cytochrome P-450 Monooxygenase,Cytochrome P-450 Oxygenase,Cytochrome P-450 Superfamily,Cytochrome P450,Cytochrome P450 Superfamily,Cytochrome p450 Families,P-450 Enzymes,P450 Enzymes,Cytochrome P 450,Cytochrome P 450 Dependent Monooxygenase,Cytochrome P 450 Enzyme,Cytochrome P 450 Enzyme System,Cytochrome P 450 Enzymes,Cytochrome P 450 Families,Cytochrome P 450 Monooxygenase,Cytochrome P 450 Oxygenase,Cytochrome P 450 Superfamily,Enzyme, Cytochrome P-450,Enzyme, P-450,Enzyme, P450,Enzymes, Cytochrome P-450,Enzymes, P-450,Enzymes, P450,Monooxygenase, Cytochrome P-450,Monooxygenase, Cytochrome P-450-Dependent,P 450 Enzyme,P 450 Enzymes,P-450 Enzyme, Cytochrome,P-450 Enzymes, Cytochrome,Superfamily, CYP450,Superfamily, Cytochrome P-450,Superfamily, Cytochrome P450
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001711 Biotransformation The chemical alteration of an exogenous substance by or in a biological system. The alteration may inactivate the compound or it may result in the production of an active metabolite of an inactive parent compound. The alterations may be divided into METABOLIC DETOXICATION, PHASE I and METABOLIC DETOXICATION, PHASE II.
D012486 Salmonella typhimurium A serotype of Salmonella enterica that is a frequent agent of Salmonella gastroenteritis in humans. It also causes PARATYPHOID FEVER. Salmonella typhimurium LT2

Related Publications

A W Wood, and R L Chang, and W Levin, and P E Thomas, and D Ryan, and T A Stoming, and D R Thakker, and D M Jerina, and A H Conney
December 1978, Biochemical and biophysical research communications,
A W Wood, and R L Chang, and W Levin, and P E Thomas, and D Ryan, and T A Stoming, and D R Thakker, and D M Jerina, and A H Conney
January 1983, Toxicology letters,
A W Wood, and R L Chang, and W Levin, and P E Thomas, and D Ryan, and T A Stoming, and D R Thakker, and D M Jerina, and A H Conney
September 1986, Toxicology and applied pharmacology,
A W Wood, and R L Chang, and W Levin, and P E Thomas, and D Ryan, and T A Stoming, and D R Thakker, and D M Jerina, and A H Conney
February 1983, Biochemical pharmacology,
A W Wood, and R L Chang, and W Levin, and P E Thomas, and D Ryan, and T A Stoming, and D R Thakker, and D M Jerina, and A H Conney
December 1974, Bulletin of the Chest Disease Research Institute, Kyoto University,
A W Wood, and R L Chang, and W Levin, and P E Thomas, and D Ryan, and T A Stoming, and D R Thakker, and D M Jerina, and A H Conney
November 1995, Biochemistry and molecular biology international,
A W Wood, and R L Chang, and W Levin, and P E Thomas, and D Ryan, and T A Stoming, and D R Thakker, and D M Jerina, and A H Conney
February 1976, Proceedings of the National Academy of Sciences of the United States of America,
A W Wood, and R L Chang, and W Levin, and P E Thomas, and D Ryan, and T A Stoming, and D R Thakker, and D M Jerina, and A H Conney
January 1990, Chemical research in toxicology,
A W Wood, and R L Chang, and W Levin, and P E Thomas, and D Ryan, and T A Stoming, and D R Thakker, and D M Jerina, and A H Conney
January 1983, Mutation research,
A W Wood, and R L Chang, and W Levin, and P E Thomas, and D Ryan, and T A Stoming, and D R Thakker, and D M Jerina, and A H Conney
July 1980, Cancer research,
Copied contents to your clipboard!